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 Abstract  We report the use of a novel hybrid near-infrared spectrometer for the 
measurement of optical scattering, pathlength and chromophore concentration in 
critically ill patients with brain injury. Ten mechanically ventilated patients with 
acute brain injury were studied. In addition to standard neurointensive care monitor-
ing, middle cerebral artery  ﬂ ow velocity, brain lactate–pyruvate ratio (LPR) and 
brain tissue oxygen tension were monitored. The patients were subjected to graded 
normobaric hyperoxia (NBH), with the inspired fraction of oxygen increased from 
baseline to 60% then 100%. NBH induced signi ﬁ cant changes in the concentrations 
of oxyhaemoglobin, deoxyhaemoglobin and oxidised–reduced cytochrome  c oxi-
dase; these were accompanied by a corresponding reduction in brain LPR and 
increase in brain tissue oxygen tension. No signi ﬁ cant change in optical scattering or 
pathlength was observed. These results suggest that the measurement of chromophore 
concentration in the injured brain is not confounded by changes in optical scattering 
or pathlength and that NBH induces an increase in cerebral aerobic metabolism. 
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 1  Introduction 
 The identi ﬁ cation and avoidance of cerebral hypoxia/ischaemia is a central tenet of 
contemporary neurocritical care, and near-infrared spectroscopy (NIRS) has a 
potential monitoring role in this regard. However, whilst a plethora of studies 
describe the use of “cerebral oximeter” devices—which express absolute scaled 
concentrations of oxyhaemoglobin and deoxyhaemoglobin ([HbO 2 ] and [HHb], 
respectively) in the form of a combined regional haemoglobin oxygen saturation—
few studies outside the context of cardiopulmonary bypass link brain desaturation 
with neurological outcome or support the routine clinical use of such devices  [ 1 ] . 
 Cytochrome  c oxidase (CCO) is the terminal electron acceptor in the mitochon-
drial electron transport chain and responsible for 95% of cellular oxygen utilisation. 
Like haemoglobin, the oxidised and reduced forms of CCO have characteristic 
absorption spectra within the NIR band; these can be measured as the difference 
spectrum of oxidised–reduced CCO. However, changes in optical scattering and 
pathlength could potentially confound the accurate measurement of oxidised–
reduced CCO concentration ([oxCCO]) in vivo  [ 2 ] . 
 The aim of this study is to measure optical scattering, pathlength and changes in 
chromophore concentration in a cohort of brain-injured patients during normobaric 
hyperoxia (NBH). 
 2  Methods 
 After approval by the institutional Research Ethics Committee and representative 
consent, recordings were carried out in ten sedated, mechanically ventilated acute 
brain-injured patients on the neurocritical care unit. These patients were subjected 
to NBH protocol, which consisted of a 60-min epoch of baseline recording, fol-
lowed by 60-min epochs where the inspired fraction of oxygen (FiO 2 ) was increased 
to 60% and then 100%, followed by a  ﬁ nal 30-min epoch where FiO 2 was returned 
to baseline values. In patients with a baseline FiO 2 of  ³ 50%, the 60% FiO 2 epoch 
was omitted. 
 Systemic physiological monitoring included arterial blood pressure (ABP), pulse 
oximetry and intermittent measurement of arterial blood gases (ABGs)—including 
partial pressures of oxygen and carbon dioxide (PaO 2 and PaCO 2 , respectively). 
Cerebral monitoring was positioned ipsilaterally to the more injured hemisphere 
and included transcranial Doppler (TCD) ultrasonography measurement of middle 
cerebral artery  ﬂ ow velocity (Vmca) (DWL Doppler Box, Compumedics Germany), 
measurement of the lactate–pyruvate ratio (LPR) by cerebral microdialysis (Dipylon 
Medical AB, Solna, Sweden) and continuous measurement of brain tissue oxygen 
tension (pbrO 2 ) (Licox, Integra Neurosciences, Plainsboro, USA). 
 The hybrid optical spectrometer has been described in detail elsewhere  [ 3 ] . Brie ﬂ y, 
it comprises two identical broadband spectrometers and a two-channel frequency 
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domain (FD) spectrometer capable of absolute measurements of optical absorption 
and scattering coef ﬁ cients ( m 
a
 and  m 
s
 , respectively) at 690, 750, 790 and 850 nm. 
[HHb], [HbO 2 ] and [oxCCO] were calculated using the UCLn algorithm  [ 4 ] ,  ﬁ tting 
to changes in NIR attenuation from 780 to 900 nm. Differential pathlength factor 
(DPF) was derived from  m 
a
 and  m 
s
 measured at 790 nm during the baseline period of 
recording, with additional correction applied for the wavelength dependence of 
pathlength  [ 5 ] . Optodes were placed in the mid-pupillary line on the forehead, ipsi-
lateral to the TCD and invasive monitoring. Chromophore concentrations derived 
from the 35 mm source–detector separation are presented. 
 Cerebral LPR was measured at 15-min intervals and ABGs at 30-min intervals. 
The remaining systemic, cerebral and NIRS variables were synchronised and moni-
tored continuously, with the mean value from a noise-free window comprising 
 ³ 50% of each entire epoch used for subsequent analysis and reporting. 
 All values are reported as median ± interquartile range (IQR) except where 
otherwise stated. Probability was calculated using a Wilcoxon signed-rank test 
comparing the difference between the initial baseline and subsequent study epochs. 
A Bonferroni correction for repeated measures was applied and  p < 0.017 de ﬁ ned as 
the level of statistical signi ﬁ cance. 
 3  Results 
 Patient demographics are summarised in Table  10.1 . The NBH protocol induced 
signi ﬁ cant changes in paO 2 and pbrO 2 , but not in paCO 2 or Vmca (Table  10.2 ). 
 The FD spectrometer failed to collect data at 750 nm in two patients and at 790 
and 850 nm in one patient. The remaining data revealed no signi ﬁ cant change 
observed in the values of  m 
s
 and DPF at any wavelength (Table  10.3 ). 
 Changes in chromophore concentration are shown in Fig.  10.1 . There was a sta-
tistically signi ﬁ cant increases in [HbO 2 ] and [oxCCO] and decreases in [HHb] dur-
ing NBH (∆[HbO 2 ]: +0.36 and +0.58  m mol l −1 ; ∆[HHb]: −0.54 and −1.56  m mol l −1 ; 
∆[oxCCO]: +0.15 and +0.28  m mol l −1 during 60% FiO 2 and 100% FiO 2 phases, 
respectively). The baseline median LPR was 24.4 (IQR 22.2–25.7) and showed a 
statistically signi ﬁ cant decrease during NBH (∆LPR: −2.8 and −3.3 during 100% 
FiO 2 and return-to-baseline epochs, respectively) and a nonsigni ﬁ cant decrease of 
−0.8 during the 60% FiO 2 phase ( p < 0.019). 
 Table 10.1  Data on patient demographics 
 Patient demographics 
 Age (range)  45.5 (23–74) 
 Sex  7 Females, 3 males 
 Pathology  4 Traumatic brain injury, 6 subarachnoid haemorrhage 
 Median Admission Glasgow 
Coma Score (IQR) 
 7.5 (4–8) 
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 4  Discussion 
 We have used a hybrid optical spectrometer to measure optical scattering, path-
length, changes in oxy- and deoxyhaemoglobin concentrations and changes in CCO 
oxidation state during NBH in ten critically ill brain-injured patients. 
 Changes in chromophore concentration, and in particular [oxCCO], have been 
reported before in a clinical context: the pattern of [oxCCO] change has been related 
to clinical outcome following cardiopulmonary bypass  [ 6 ] and our group have pre-
viously demonstrated an increase in [oxCCO] with NBH  [ 7 ] and heterogeneous 
changes with hypercapnoea  [ 8 ] . However, changes in optical scattering and path-
length have been proposed as key confounding factors in the measurement of 
[oxCCO]  [ 2 ] and the effects of changes in pathlength and scattering on [oxCCO] 
measurement have been hitherto unknown. 
 We have adopted a novel approach that combines simultaneous measurement of 
optical scattering and pathlength in addition to measurement of changes in chro-
mophore concentration and LPR. The concordance between the microdialysis and 
[oxCCO], combined with the absence of changes in either  m 
s
 or pathlength, suggests 
 Table 10.3  Median (IQR) values for measured optical scattering coef ﬁ cient ( m 
s
 ) and differential 
pathlength factors at four wavelengths 
 Baseline  FiO 2 60%  FiO 2 100%  Return to baseline 
 m 
s
 690 nm (cm −1 )  10.8(9.05–10.8)  10.6(10.1–12.3)  10.5(9.74–12.4)  10.3(9.39–12.5) 
 m 
s
 750 nm (cm −1 )  9.93(9.02–10.2)  10.0(9.04–10.5)  9.76(9.00–10.6)  9.89(8.99–10.7) 
 m 
s
 790 nm (cm −1 )  9.48(8.8–9.75)  9.49(8.59–11.5)  9.25(8.25–11.8)  9.10(7.44–11.8) 
 m 
s
 850 nm (cm −1 )  9.10(9.0–9.70)  9.40(8.76–9.80)  9.36(8.68–9.54)  9.35(8.9–9.4) 
 DPF 690 nm  8.40(8.33–8.71)  8.634(8.52–9.44)  8.88(8.49–9.57)  8.54(8.03–9.37) 
 DPF 750 nm  8.15(7.9–8.24)  8.12(7.76–8.44)  8.32(7.96–9.11)  8.15(7.87–9.05) 
 DPF 790 nm  8.14(8.12–8.28)  8.24(7.91–8.49)  8.21(7.92–8.81)  7.98(7.89–8.63) 
 DPF 850 nm  8.07(8.06–8.52)  8.00(7.73–8.40)  7.94(7.66–8.37)  8.00(7.83–8.31) 
 No variable showed statistically signi ﬁ cant variation from baseline 
 Table 10.2  Median (IQR) values for monitored physiological variables during four phases of 
experiment 
 Baseline  FiO 2 60%  FiO 2 100%  Return to baseline 
 ABP (mmHg)  89.9 
 (81.4–95.2) 
 94.6 
 (82.9–99.7) 
 95.2 
 (90.7–97.1) 
 90.7 
 (84.3–93.2) 
 paO 2 (kPa)  13.9 
 (11.7–18.1) 
 26.6* 
 (25.8–31.1) 
 52.9* 
 (49.2–57.0) 
 11.8 
 (10.9–14.4) 
 paCO 2 (kPa)  4.8 
 (4.6–5.0) 
 5.0 
 (4.8–5) 
 4.8 
 (4.6–4.9) 
 5.1 
 (4.7–5.5) 
 pbrO 2 (kPa)  2.8 
 (1.6–3.4) 
 4.0*(2.5–4.7)  7.4*(5.6–8.6)  3.5(1.7–4.7) 
 Vmca (cm s −1 )  54.3(51.3–79.6)  56.2(48.7–84.7)  54.3(50.3–83.1)  57.1(51.8–86.1) 
 Values showing a statistically signi ﬁ cant difference from initial baseline are italicised 
 * p < 0.01 
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 Fig. 10.1  Changes in: ( a ) oxyhaemoglobin ( open circles ) and deoxyhaemoglobin ( solid circles ); 
( b ) microdialysate lactate–pyruvate ratio; ( c ) haemoglobin difference; ( d ) oxidised–reduced cyto-
chrome  c oxidase for each phase of study.  B baseline,  60% FiO 2 60%,  100% FiO 2 100%,  RTB 
return to baseline. * p < 0.017; ** p < 0.01 comparing study epoch to initial baseline 
that scattering and pathlength changes do not confound the measurement of 
chromophore concentration and that the change in [oxCCO] seen during NBH 
therefore represents an actual increase in mitochondrial aerobic metabolism. 
 The pattern of chromophore concentration change that we have observed during 
NBH is similar to that previously reported by our group using different apparatus in 
a cohort patients who had a similar median age and admission GCS, but had a pri-
mary diagnosis of traumatic brain injury rather than the mixed group of traumatic 
and vascular brain injuries reported in this study. The magnitude of [HbO 2 ] increase, 
however, was smaller in our cohort than that previously reported. The reasons for 
this are unclear, but may include pathophysiological and instrumentation factors. 
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Interpreting the physiological mechanisms underlying the increase in [oxCCO] in 
response to NBH is challenging, but may be enhanced by the use of a mathematical 
model of the cerebral circulation and metabolism  [ 9 ] . Further work is required to 
elucidate the relationship between [oxCCO] and changes in cerebral oxygen avail-
ability and may aid in the translation of NIRS-derived measurement of [oxCCO] 
from a research to a clinical tool. 
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